| J9271 | Injection, pembrolizumab, 1 mg | 5,800 | $40 | $249.4K |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 1,760 | $20 | $38.7K |
| Q5103 | Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg | 1,810 | $20 | $30.8K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 210 | $110 | $22.6K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 160 | $90 | $14.5K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 270 | $40 | $11.7K |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 1,830 | $10 | $11K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 70 | $80 | $5.5K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 40 | $120 | $4.2K |
| 99195 | The provider removes venous blood from a patient, similar to a blood donation, to reduce the number of red blood cells or treat a high level of iron or potassium in the blood. | 60 | $60 | $3.7K |